ALEXANDRA MEIHOFER: Open Payments
NPI 1942965934 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$163 in 6 payments from 6 companies in 2025. Trend: 2023 $82 · 2024 $162 · 2025 $163
Food & beverage: $163
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $35 |
| Lilly USA, LLC | 1 | $33 |
| Alnylam Pharmaceuticals Inc. | 1 | $28 |
| Gilead Sciences, Inc. | 1 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| ORPHALAN INC | 1 | $19 |
Products named: Ozempic, MOUNJARO, GIVLAARI, Livdelzi, IQIRVO, CUVRIOR.
Industry payments across CO — which companies pay providers there.
